Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
Axea concentrated 83.85% of July 2026 sales in Oil, where year-over-year declined 50.18% and month-over-month fell 29.35, while Topical rose to 16.15% share with a 379.56% year-over-year surge and a 29.34% month-over-month increase; the average price fell 7.15% year-over-year to $40.20. Despite Axea’s Oil anchor, the brand’s Oil rank sat at 16 in Ontario and overall brand sales were down 41.74% year-over-year and 77.48% versus 24 months, implying category dependence amplified volatility as Oil contracted while Topical expansion only partially offset losses.
The pivot toward Topical—up 379.56% year-over-year while Oil dropped 50.18%—suggests Axea is repositioning from a single-category Oil profile (83.85% share) toward a more balanced mix, yet the 29.35% month-over-month Oil contraction against a 29.34% Topical gain indicates mix shifts are reactive rather than scaled. With a 16 rank in Oil in Ontario and a 7.15% price decrease alongside a 29.34% month-over-month Topical lift, the pattern implies Axea’s near-term positioning leans on value-led Topical growth to stabilize demand while Oil’s weight continues to pull overall performance down.
Competitive Landscape
Axea is currently ranked #16 in ON Oil in July 2026, down 3 spots year over year from #13, but up 2 positions from #18 in April 2026; that combination of a 3-position YoY decline and a 2-position quarter-to-date recovery places Axea well below its peak of #8 in February 2025 while indicating some near-term stabilization. In contrast, Mod sits at #1 after improving from #2 year over year with sales up 11.53%, while Redecan slid from #1 to #2 with sales down 26.83%, and MediPharm Labs held #3 with a 4.63% sales decline; this mix of competitor gains and losses suggests Axea’s downward YoY rank movement is less about category contraction and more about share being captured by faster-moving leaders. The pattern implies Axea’s rank trajectory is drifting from its historical ceiling toward the mid-teens unless it reclaims share from competitors that are either climbing or holding ground.

Notable Products
THC-Free Be Well CBG Isolate Oil (30ml) posted the steepest decline at -69.2% month over month while sitting at rank 4, and CBN/CBD Nighttime THC-Free Isolate Oil (30ml) fell -54.7% at rank 2, signaling concentrated fragility in Axea’s specialty Oil lineup. THC-Free Daytime CBD Isolate Oil (30ml) remained rank 1 despite a -7.1% pullback, while THC Pure Isolate Oil (30ml) inched up +1.8% at rank 6, and three of the top six SKUs are Oils, pointing to category reliance with uneven velocity. CBD Frankinsence Dead Sea Pink Himalayan Bath Salt (250mg CBD, 250g) dropped -31.0% at rank 2 in Topicals, and CBD Beard Grooming Oil (300mg CBD, 30ml) contracted -57.3% at rank 5, indicating that non-core adjuncts are not offsetting Oil volatility. The mix implies Axea is anchored to a flagship Oil that still leads on rank 1 and roughly $8.2k in July 2026 sales, but deeper growth will require stabilizing nighttime/CBG Oils and pruning weaker Topicals to reduce month-to-month swings.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.






